Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate

Journal of Urology

Volumn 174, Issue 2, 2005, Pages 514-518

  Uetsuki, Hirotsugu ^a,b   Tsunemori, Hiroyuki ^a   Taoka, Rikiya ^a   Haba, Reiji ^a   Ishikawa, Masashi ^a   Kakehi, Yoshiyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Nuclear matrix associated proteins; Prostate; Prostatic intraepithelial neoplasia; Prostatic neoplasms; Tumor markers, biological

Indexed keywords

BIOLOGICAL MARKER; CD45RO ANTIGEN; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; PROTEIN EPCA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATROPHY; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CELL NUCLEUS MATRIX; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; PRECANCER; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION;

EID: 22144469089     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000165154.41159.b1     Document Type: Article

References (12)

1. Brunagel, G., Schoen, R. E., Bauer, A. J., Vietmeier, B. N. and Getzenberg, R. H.: Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res, 8: 3039, 2002
2. Partin, A. W., Getzenberg, R. H., CarMichael, M. J., Vindivich, D., Yoo, J., Epstein, J. I. et al: Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res, 53: 744, 1993
3. Getzenberg, R. H., Pienta, K. J., Huang, E. Y. and Coffey, D. S.: Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res, 51: 6514, 1991
4. Dhir, R., Vietmeier, B., Arlotti, J., Acquafondata, M., Landsittel, D., Masterson, R. et al: Early identification of individuals with prostate cancer in negative biopsies, J Urol, 171: 1419, 2004
5. Sobin, L. H. and Witteking, C.: TNM Classification of Malignant Tumours, 5th ed. New York: Wiley-Liss, 1997
6. Xu, J., Stolk, J. A., Zhang, X., Silva, S. J., Houghton, R. L., Matsumura, M. et al: Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res, 6: 1677, 2000
7. Jiang, Z., Woda, B. A., Rock, K. L., Xu, Y., Savas, L., Khan, A. et al: P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol, 25: 1397, 2001
8. Shah, R. B., Zhou, M., LeBlanc, M., Snyder, M. and Rubin, M. A.: Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol, 26: 1161, 2002
9. Taoka, R., Tsukuda, F., Ishikawa, M., Haba, R. and Kakehi, Y.: Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia, J Urol, 171: 2330, 2004
10. Pienta, K. J., Partin, A. W. and Coffey, D. S.: Cancer as a disease of DNA organization and dynamic cell structure, Cancer Res, 49: 2525, 1989
11. De Marzo, A. M., Marchi, V. L., Epstein, J. I. and Nelson, W. G.: Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol, 155: 1985, 1999
12. Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L. et al: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol, 22: 2790, 2004